Multiple Sclerosis

被引:37
作者
Files, Daniel Kane [1 ]
Jausurawong, Tani [1 ]
Katrajian, Ruba [1 ]
Danoff, Robert [1 ]
机构
[1] Aria Hlth, Emergency Med Residency, Combined Family Med, Family Med Residency, Philadelphia, PA 19114 USA
来源
PRIMARY CARE | 2015年 / 42卷 / 02期
关键词
Multiple sclerosis; Vitamin D; Epstein-Barr virus; Latitude; NATALIZUMAB; MANAGEMENT; DIAGNOSIS; TRIAL;
D O I
10.1016/j.pop.2015.01.007
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Multiple sclerosis (MS) is a chronic, debilitating disease that can have devastating effects. Presentation varies widely in symptoms, pace, and progression. In addition to a thorough history and physical examination, diagnostic tools required to diagnose MS and exclude other diagnoses include MRI, evoked potential testing, and cerebrospinal fluid analysis. Although the disease is not curable presently, quality of life can be improved by minimizing the frequency and severity of disease burden. Disease modification, symptom management, preservation of function, and treatment of psychosocial issues are paramount to enhance the quality of life for the patient affected with MS.
引用
收藏
页码:159 / +
页数:18
相关论文
共 36 条
  • [1] Neuroimaging in Multiple Sclerosis
    Ali, Eman N.
    Buckle, Guy. L.
    [J]. NEUROLOGIC CLINICS, 2009, 27 (01) : 203 - +
  • [2] [Anonymous], MS OV WHAT IS MULT S
  • [3] [Anonymous], 2014, HLA DRB1 MAJ HIST CO
  • [4] Vitamin D and multiple sclerosis
    Ascherio, Alberto
    Munger, Kassandra L.
    Simon, K. Claire
    [J]. LANCET NEUROLOGY, 2010, 9 (06) : 599 - 612
  • [5] CD40: Novel Association with Crohn's Disease and Replication in Multiple Sclerosis Susceptibility
    Blanco-Kelly, Fiona
    Matesanz, Fuencisla
    Alcina, Antonio
    Teruel, Maria
    Diaz-Gallo, Lina M.
    Gomez-Garcia, Maria
    Lopez-Nevot, Miguel A.
    Rodrigo, Luis
    Nieto, Antonio
    Cardena, Carlos
    Alcain, Guillermo
    Diaz-Rubio, Manuel
    de la Concha, Emilio G.
    Fernandez, Oscar
    Arroyo, Rafael
    Martin, Javier
    Urcelay, Elena
    [J]. PLOS ONE, 2010, 5 (07): : 1 - 4
  • [6] Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
    Bloomgren, Gary
    Richman, Sandra
    Hotermans, Christophe
    Subramanyam, Meena
    Goelz, Susan
    Natarajan, Amy
    Lee, Sophia
    Plavina, Tatiana
    Scanlon, James V.
    Sandrock, Alfred
    Bozic, Carmen
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (20) : 1870 - 1880
  • [7] Calabresi PA, 2004, AM FAM PHYSICIAN, V70, P1935
  • [8] Environmental factors and multiple sclerosis
    Ebers, George C.
    [J]. LANCET NEUROLOGY, 2008, 7 (03) : 268 - 277
  • [9] Banting Lecture 2009: An Unfinished Journey: Molecular Pathogenesis to Prevention of Type 1A Diabetes
    Eisenbarth, George S.
    [J]. DIABETES, 2010, 59 (04) : 759 - 774
  • [10] Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
    Fox, Robert J.
    Miller, David H.
    Phillips, J. Theodore
    Hutchinson, Michael
    Havrdova, Eva
    Kita, Mariko
    Yang, Minhua
    Raghupathi, Kartik
    Novas, Mark
    Sweetser, Marianne T.
    Viglietta, Vissia
    Dawson, Katherine T.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (12) : 1087 - 1097